• Why the Appen (ASX:APX) share price is sinking 5% today

    Thumbs down Facebook icon over dark screen

    The Appen Ltd (ASX: APX) share price has come under pressure on Tuesday.

    In morning trade, the artificial intelligence data services company’s shares were down 5% to $12.26.

    When the Appen share price hit that level, it meant it was down by over 51% since the start of the year.

    Why is the Appen share price under pressure?

    Investors have been selling down the Appen share price today despite there being no news out of the company or broker notes that I’m aware of.

    However, something that could be weighing on its shares was a recent ceasing to be a substantial holder notice.

    According to the notice from Monday, the Capital Group Companies has been selling a large number of shares on-market in recent weeks and as recently as 1 July. On that particular day, the fund manager sold 583,170 shares for just a touch over $8 million.

    This may have investors concerned as it was only just over a month ago when the fund manager, which has over US$2 trillion in assets under management, was loading up on Appen shares. It appears as though Capital Group Companies has changed its mind about Appen pretty quickly. However, it isn’t immediately apparent why at this stage.

    Is this a buying opportunity?

    The current Appen share price could have a lot of potential upside based on some recent broker notes.

    According to a note out of Ord Minnett in late May, its analysts have a buy rating and $24.75 price target on its shares. This implies over 100% upside over the next 12 months if its analysts are on the money.

    Even analysts at Credit Suisse, which have just a neutral rating on its shares, see decent upside from here. Their $15.00 price target offers potential upside of ~22% over the next 12 months.

    The post Why the Appen (ASX:APX) share price is sinking 5% today appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Appen right now?

    Before you consider Appen, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Appen wasn’t one of them.

    The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of May 24th 2021

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Appen Ltd. The Motley Fool Australia owns shares of and has recommended Appen Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3dLtVJ3

  • The 3 ASX shares that top brokers just upgraded to “buy”

    ASX shares upgrade asx 200 share price upgrade to buy represented by hand drawing line under the word upgrade

    Experts believe the market is set to rise further this year and leading brokers have just put forward three new ASX shares that they just upgraded to “buy” for your watchlist.

    The S&P/ASX 200 Index (Index:^AXJO) gained 0.2% this morning and is up nearly 10% since January. Several equity experts believe ASX shares will continue to do well – at least for the rest of this year if not beyond.

    Despite the big gains on the ASX, there are still buying opportunities on the market. One example is the IGO Ltd (ASX: IGO) share price even as it raced to a 13-year high.

    ASX shares getting a big boost from broker upgrade

    The lithium and nickel miner jumped 3.8% to $8.29 during lunch time trade – making it the third best performer on the ASX 200.

    Only the Whitehaven Coal Ltd (ASX: WHC) share price and EML Payments Ltd (ASX: EML) share price are besting it with gains of over 5% each.

    Investors are getting excited about the IGO share price after Goldman Sachs upgraded it to “buy”. The upgrade comes as IGO successfully completes its acquisition of a 49% stake in Tianqi Lithium Energy Australia (TLEA).

    What is the IGO share price worth?

    “We forecast the acquisition will be EPS accretive from FY23 and cash flow accretive from FY25, driven by a strengthening lithium price and the ramp up of production,” said Goldman.

    The broker believes IGO is well placed to benefit from the expected boom in battery demand. The miner is positioned in the bottom quartile of the cost curve across nickel, spodumene, and lithium hydroxide.

    The broker’s 12-month price target on the IGO share price is $9.30 a share.

    Playing a better game

    Meanwhile, the Tabcorp Holdings Limited (ASX: TAH) also got upgraded by Morgans. The broker lifted its rating on the gaming group to “add” from “hold” following Tabcorp’s demerger announcement.

    The group intends to split into two ASX-listed entities. One will control Lotteries and Keno (L&K), while the other will hold the wagering and media businesses.

    Demerger drives “buy” upgrade for this ASX share

    “We are attracted to L&K’s infrastructure-like qualities, which have clearly been illustrated through its financial performance during the pandemic,” said Morgans.

    “We think the demerger has the potential to unlock the value inherent in the high quality L&K business.”

    The broker’s 12-month price target for the combined group increased to $5.66 fron $5.11 a share.

    Better placed for the commodity upswing

    Another ASX shares that got upgraded by Morgans to “add” from “hold” is the Coronado Global Resources Inc (ASX: CRN) share price.

    The broker took a more bullish view of the miner after it successfully refinanced its debt and undertook a capital raising.

    The repair to its balance sheet is timely as it coincides with a sharp rise in global coking coal prices.

    “Physical market participants – producers, traders, buyers – are increasingly of the view that stronger pricing will persist into end-CY21 on higher steel pricing,” added Morgans.

    “Very strong Chinese demand is clearly spilling over into pricing into markets ex-China.”

    The broker’s 12-month price target on the Coronado share price is $1.06 a share.

    The post The 3 ASX shares that top brokers just upgraded to “buy” appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

    *Returns as of May 24th 2021

    More reading

    Motley Fool contributor Brendon Lau owns shares of IGO Ltd. Connect with me on Twitter @brenlau.

    The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended EML Payments. The Motley Fool Australia owns shares of and has recommended EML Payments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/2TvHSEd

  • Here’s why the Opthea (ASX:OPT) share price is soaring 8%

    A woman sits inside a cubicle undergoing an eyetest

    The Opthea Ltd (ASX: OPT) share price is soaring today, up more than 8% trading at $1.37 at the time of writing.

    The clinical stage biopharmaceutical company is focused on developing therapies to treat progressive retinal diseases.

    Below, we look at the company’s latest update from its United States’ endeavours.

    What update did Opthea announce?

    Opthea’s share price is rocketing after the company reported that it had received Fast Track designation from the US Food and Drug Administration (FDA) for its product to treat patients with neovascular (wet) age-related macular degeneration (AMD).

    Opthea said the Fast Track designation for its VEGF-C/-D ‘trap’ inhibitor, OPT-302, used in combination with anti-VEGF-A therapy, recognises the potential role that OPT-302 has for addressing significant unmet needs to manage neovascular AMD.

    The FDA’s Fast Track designation opens the door to Opthea for improved communications with the administration. It said a rolling review process enabled by the designation will help speed up its Phase 3 development program and approval review processes.

    It noted that OPT-302 may now also be eligible for accelerated approval and priority review as long as it meets the needed criteria.

    Commenting on the Fast Track approval, Opthea’s CEO Megan Baldwin said:

    The recognition from the FDA to grant OPT-302 Fast Track designation reflects the seriousness of wet AMD as a debilitating eye disease and the importance of advancing new therapies such as OPT-302 to address the significant unmet medical need for wet AMD patients, many of whom experience an incomplete response to VEGF-A inhibitors despite regular, ongoing therapy.

    By targeting a novel mechanism of action, OPT-302 has the potential to be a truly differentiated treatment option that when used in combination offers patients improved vision outcomes over standard of care anti-VEGF-A monotherapy.

    Opthea said it was currently recruiting patients for 2 simultaneous global Phase 3 trials, with some 990 patients expected in each.

    Opthea share price snapshot

    Despite today’s rise, the Opthea share price remains down 45% over the past 12 months, during a period that saw the All Ordinaries Index (ASX: XAO) gain 24%.

    Year-to-date, the Opthea share price has remained under pressure, down 30%.

    The post Here’s why the Opthea (ASX:OPT) share price is soaring 8% appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Opthea right now?

    Before you consider Opthea, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Opthea wasn’t one of them.

    The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of May 24th 2021

    More reading

    The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3qMjjPv

  • Why the Aeris (ASX:AIS) share price is jumping 10%

    happy child jumping for joy

    The Aeris Resources Ltd (ASX: AIS) share price is jumping for joy. At the time of writing, shares in the mineral explorer are swapping hands for 19.75 cents each – up 9.72%.

    The massive price rise comes after the company announced “tremendous” copper results from its mine in western New South Wales.

    Let’s take a closer look at today’s results.

    The Aeris share price is rising

    In a statement to the ASX, Aeris Resources announced a series of “high grade” copper intersections at its Constellation deposit within its Tritton mine in NSW.

    Highlights include:

    • a 13m wide ore containing 8.64% copper.
    • an 11m wide ore containing 8.63% copper.
    • a 9m wide ore containing 8.20% copper, and
    • an 11m wide ore containing 4.63% copper.

    As well, Aeris declared more high-grade copper mineralisation near the surface, a positive indication for future exploration. Investors clearly believe so too judging by the rising Aeris share price.

    Management commentary

    Aeris Executive Chair Andre Labuschagne said:

    The RC drill program has been a tremendous success. To say that the near surface drilling results at Constellation have surprised on the upside would be an understatement.

    A number of the RC drill holes encountered excessive water and had to be discontinued whilst still in visible mineralisation. RC drilling has been suspended whilst we complete these holes with a diamond tail. This is expected to be completed in the next couple of weeks.

    Copper commodity price

    Copper is currently trading on the commodities market for US$4.36 per pound. It’s up nearly 1% today, 2.1% this week, and 24.1% year-to-date.

    According to the website Trading Economics, copper prices have slipped somewhat over the past 2 months as supply comes back online. The website says its relatively high price, however, is due to strong demand from sustained economic growth in the US.

    Looking forward, Trading Economics says copper is forecast to rise to $5.00 per pound over the next 12 months.

    Aeris share price snapshot

    During the past 12 months, the Aeris share price has increased by 400%. Its current share price is only just off its 52-week high of 23 cents per share.

    Aeris Resources has a market capitalisation of $434 million.

    The post Why the Aeris (ASX:AIS) share price is jumping 10% appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Aeris right now?

    Before you consider Aeris, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Aeris wasn’t one of them.

    The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of May 24th 2021

    More reading

    from The Motley Fool Australia https://ift.tt/3hCNXXf

  • ASX 200 up 0.2%: Westpac asset sale, Ramsay increases Spire offer

    man thinking about whether to invest in bitcoin

    At lunch on Tuesday, the S&P/ASX 200 Index (ASX: XJO) is on track to record another small gain. The benchmark index is currently up 0.2% to 7,329.5 points.

    Here’s what’s happening on the market today:

    Westpac asset sale

    The Westpac Banking Corp (ASX: WBC) share price is pushing higher today after announcing an agreement to sell its Westpac Life NZ business. The banking giant is selling the business to Fidelity Life Assurance Company for NZ$400 million (approximately A$373 million). The two parties have also entered into an exclusive 15-year agreement for the distribution of life insurance products to Westpac’s New Zealand customers. This is expected to result in a post-tax gain on sale and add approximately 7 basis points to the bank’s group common equity tier 1 capital ratio.

    Ramsay increases offer for Spire

    The Ramsay Health Care Limited (ASX: RHC) share price is trading largely flat today after increasing its takeover offer for UK-based private hospital operator, Spire Healthcare. According to the release, Ramsay has increased its cash offer to acquire Spire to 250 pence per share in cash. This compares to its previous offer of 240 pence per share. This values Spire’s entire issued and to be issued share capital at approximately GBP1,041 million (A$1,900 million) on a fully diluted basis. Management advised that this is its final offer.

    Ramelius falls short of guidance

    The Ramelius Resources Limited (ASX: RMS) share price is under pressure today after falling short of its full year production guidance. For the 12 months ended 30 June, Ramelius achieved gold production of 272,109 ounces. While this was a record for the gold miner, it fell short of its upgraded guidance of 275,000 ounces to 280,000 ounces. Management blamed the miss on several issues such as rainfall and personnel shortages at the Edna May operation.

    Best and worst ASX 200 performers

    The best performer on the Genesis Energy Ltd (ASX: GNE) share price with a 6% gain on low volumes. The worst performer has been the Appen Ltd (ASX: APX) share price with a 5% decline. This appears to have been driven by a fund manager selling down its holding.

    The post ASX 200 up 0.2%: Westpac asset sale, Ramsay increases Spire offer appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

    *Returns as of May 24th 2021

    More reading

    Motley Fool contributor James Mickleboro owns shares of Westpac Banking Corporation. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Appen Ltd. The Motley Fool Australia owns shares of and has recommended Appen Ltd. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3hBQ5OT

  • Calix (ASX:CXL) share price jumps 11% to all-time high

    red arrow representing a rise of the share price with a man wearing a cape holding it at the top

    The Calix Ltd (ASX: CXL) share price is flying 11% higher to all-time highs.  

    Investors are jumping for shares in the company following an announcement earlier today.

    Let’s take a look at what Calix announced and why shares in the company are in hot demand.  

    What’s been fueling the Calix share price?

    Earlier today, Calix announced that the company has executed a Memorandum of Understanding (MOU) for the development of a lime project.

    The project for lime production includes CO2 capture and multi-fuel options with UK based building company Tarmac.

    The MOU outlines the intent of both parties to conduct feasibility and Front-End Engineering Design (FEED) studies on the project.

    According to the announcement, the project is based on a 2-phase approach that will determine a Final Investment Decision (FID). Calix noted that phase 2 feasibility has a target completion date of the second quarter of 2022.

    Progression following successful feasibility studies will include construction and commercial demonstration.

    Calix also noted that commercial terms are still to be agreed between the parties for on-going licensing of the technology.

    Calix CEO and Managing Director Phil Hodgson noted;

    “… we are now proud to be working with Tarmac in the UK on a second project of equal ambition. Lime is one of the most important industrial products globally, and it is great to be developing this in partnership with Tarmac, with whom we have had a long association as part of the LEILAC Project consortium.”.

    More on the Calix share price

    The Calix share price has bolted more than 15% in the past 2 days.

    Shares in the company have been fuelled by a slew of price-sensitive news, including today’s announcement.

    Yesterday, Calix announced a partnership with London-listed company RHI Magnesita NV (LON: RHIM).

    According to its announcement, Calix has executed an MOU with RHI Magnesia to advance CO2 emissions reduction in the refractory industry.

    Calix advised that the MOU will cover the development of a Calix Flash Calciner for use in the production of refractory materials. Under the terms, both parties will undertake studies for aFEED demonstration facility.

    Overall, The Calix share price has had an outstanding year thus far. Shares in the technology company have nearly tripled after opening the year at around $1.07.

    The post Calix (ASX:CXL) share price jumps 11% to all-time high appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Calix right now?

    Before you consider Calix, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Calix wasn’t one of them.

    The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of May 24th 2021

    More reading

    Motley Fool contributor Nikhil Gangaram has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3xofWAD

  • Abacus (ASX:ABP) share price dips despite property acquisition

    property prices represented by person holding on to miniature house

    The Abacus Property Group (ASX: ABP) share price is in the red this morning after the company announced the acquisition of self-storage assets in Sydney. At the time of writing, the Abacas share price is trading 0.91% lower at $3.25 apiece. Let’s take a look.

    What did Abacus acquire?

    Abacus announced that it had exchanged contracts to acquire a portfolio of Storage King self-storage assets located in Sydney.

    In its release, the company said the units were located in an area defined by the Australian Bureau of Statistics (ABS) as the “premium inner Sydney Significant Urban Area”.

    The acquisition comprises 5 assets, adding more than 25,000 square metres of net lettable area. They include:

    • Three mature stores located in Chatswood, Artarmon and St Leonards
    • One store in the later stage of stabilisation located in Dee Why
    • One recently developed store located in Pymble.

    Abacus expects to settle the deal on 3 August 2021 for $160 million, excluding transaction costs. The company plans to fund the acquisition from existing debt facilities.

    Management commentary

    Abacus managing director Steven Sewell said:

    The assets are located within tightly held catchments, benefitting from significant self storage demand generated from above average household incomes, large proportions of renters and continually increasing density from apartment development. The transaction also demonstrates the sustained acquisition pipeline generated from the Storage King platform.

    Sewell also commented on what the acquisition brings for its shareholders, saying:

    This transaction aligns with our strong asset backed, annuity style business model where capital is directed towards assets in key sectors that provide potential for enhanced income growth and ultimately create value.

    Abacus share price snapshot

    The Abacus share price is up 13.15% year-to-date, tracking slightly ahead of the S&P/ASX 200 Index (ASX: XJO) year-to-date return of 9.75%.

    However, ASX-listed real estate investment trusts (REITs) more broadly speaking, have largely struggled to retest pre-COVID highs.

    In the case of Abacus, its shares are still down around 19% from its mid-February 2020 prices of about $4.

    The post Abacus (ASX:ABP) share price dips despite property acquisition appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Abacus right now?

    Before you consider Abacus, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Abacus wasn’t one of them.

    The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of May 24th 2021

    More reading

    Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3ysiQoc

  • The Immutep (ASX:IMM) share price is up 6% today

    woman in lab coat conducting testing representing mesoblast share price

    Shares in Immutep Ltd (ASX: IMM) are soaring today following news of its latest drug trial. Currently, the Immutep share price is trading at 56 cents, 5.6% higher than its previous close.

    The biotechnology company has received approval from both the United States Food and Drug Association (FDA) and Institutional Review Board (IRB) to begin the trial.

    Let’s take a closer look at today’s news from Immutep.

    New trial gets US approval

    Immutep can now begin a phase IIb trial, combining its lead product candidate, eftilagimod alpha (efti), with MSD’s immunotherapy treatment, Keytruda (pembrolizumab).

    The company — which develops immunotherapy treatments for cancer and autoimmune disease — is focussing on Efti, an antigen-presenting cell activator.

    Immutep advised that the TACTI-003 trial will be a randomised, controlled clinical study. It aims to find if efti and pembrolizumab can be combined to treat head and neck squamous cell carcinoma (HNSCC).

    Immutep plans for the trial to involve around 154 patients. It hopes it will take place in Australia and Europe, as well as the United States.

    The trial is pending approval from authorities and ethics committees in Australia and Europe.

    Immutep expects patient recruitment for the trial to begin in the United States in the current quarter, with Australian and European sites to follow.

    Commentary from management

    Immutep chief scientific officer and chief medical officer Frédéric Triebel said:

    We are delighted to start our new TACTI-003 trial in 1st line HNSCC patients to evaluate efti in combination with pembrolizumab vs pembrolizumab monotherapy.

    Results we reported from this therapeutic combination earlier in June at [the American Society of Clinical Oncology] in the 2nd line setting were robust, with sustained and durable responses. We look forward to deepening these results with a larger group of 1 st line HNSCC patients in TACTI-003.

    Immutep share price snapshot

    2021 has been a good year so far for the Immutep share price on the ASX.

    It’s currently 34% higher than it was at the start of the year, and has gained 232% since this time last year.

    The company has a market capitalisation of around $407 million, with approximately 648 million shares outstanding.

    The post The Immutep (ASX:IMM) share price is up 6% today appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Immutep right now?

    Before you consider Immutep, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Immutep wasn’t one of them.

    The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of May 24th 2021

    More reading

    Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3qSx6nt

  • 2 exciting ASX growth shares that might be worth buying

    ASX shares upgrade buy Woman in glasses writing on buy on board

    There are a group of ASX shares that might be exciting ideas because of the business growth that they are generating.

    The below companies are ones that are producing fast double digit profit growth and have plans for more growth to come:

    Pinnacle Investment Management Group Ltd (ASX: PNI)

    Pinnacle is an asset manager outfit. It takes strategic stakes in some of the leading asset managers in the country and helps them grow, as well as allowing them to just focus on the investing side of things.

    Some of the managers that it’s invested in includes Firetrail, Coolabah, Hyperion and Plato.

    One of the brokers that likes Pinnacle Investment Management is Macquarie Group Ltd (ASX: MQG).

    Pinnacle can grow profit as its affiliate fund managers grow their funds under management (FUM). Macquarie believes Pinnacle’s FUM can grow to $90 billion by the end of FY21.

    The rising FUM is lead to growing profits, and is leading the broker to expect that profit growth can continue for at least the next couple of financial years. Net inflows and improving profit margins can help the business continue to produce returns.

    In the ASX growth share’s latest update, total affiliate FUM at 30 April 2021 was $84.9 billion, compared to $70.5 billion at 31 December 2020 (up 20.4%) and compared to $58.7 billion at 30 June 2020 (up 44.6%).

    Total net inflows for the four months to 30 April 2021 was $9.9 billion. That included $8.1 billion of institutional money (including $1.2 billion from offshore). It also saw $1.8 billion of retail inflows.

    Pinnacle recently said that most affiliates and strategies continue to deliver performance to expectations, or better. However, there are short-term challenges in a couple of affiliates.

    In the FY21 half-year result it grew net profit by 120%.

    According to Macquarie, the Pinnacle share price is valued at 25x FY22’s estimated earnings.

    MNF Group Ltd (ASX: MNF)

    MNF Group is a telecommunications software business. It boasts that it enables companies like Zoom, Google and Twilio to launch and scale communication services without constraints.

    It’s currently rated as a buy by the broker Morgan Stanley with a price target of $6.30. That suggest a potential return of almost 20% over the next 12 months.

    The broker likes the recent sale by MNF of part of its direct business to Vonex Limited for $31 million. The sale is in-line with the ASX growth share’s strategy to simplify the business, grow recurring revenue and focus on growing the MNF wholesale business, Symbio.

    The business is generating growth. In the FY21 half-year result, it saw recurring revenue growth of 15% to $55.7 million. Earnings before interest, tax, depreciation and amortisation (EBITDA) rose 16% to $19.6 million and underlying net profit jumped 30% to $8.4 million.

    MNF is guiding that EBITDA for FY21 will be between $40 million to $43 million.

    In Singapore it’s conducting its final technical trials with several customers, before officially going live in the Singapore market. Customer technical trials are ongoing and have been successful. It had a go-live date of 1 July 2021, pending final regulatory approval.

    According to Morgan Stanley, the MNF share price is valued at 19x FY22’s estimated earnings.

    The post 2 exciting ASX growth shares that might be worth buying appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

    *Returns as of May 24th 2021

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended MNF Group Limited. The Motley Fool Australia owns shares of and has recommended MNF Group Limited and Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3ys1p70

  • Warren Buffett owns these dividend-paying growth stocks — should you?

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    woman working ion her apple macbook

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    Generally speaking, growing companies tend to avoid dividends, opting instead to funnel any excess cash back into the business. However, that doesn’t mean it’s impossible to find dividend-paying growth stocks.

    For instance, Warren Buffett’s Berkshire Hathaway owns stock in Apple (NASDAQ: AAPL) and Mastercard (NYSE: MA), and both companies pay quarterly dividends while still having solid prospects for future growth. Here’s what investors should know.

    Apple

    Apple has built a consumer electronics empire. From Macs and iPhones to the Apple Watch and AirPods, the company’s hardware rarely fails to captivate its customers. In fact, Apple had a worldwide installed base of over 1.65 billion devices as of its fiscal 2021 first quarter, and that number is likely to climb with the recent launch of its M1-powered iMac and iPad Pro.

    So what’s driving that popularity? One of Apple’s greatest advantages is iOS, the operating system that powers its mobile devices. Unlike Android, iOS is closed-source, meaning no third party can install it on their own hardware to create a cheaper “Apple-like” experience. In other words, if you want the Apple experience, you have to pay for it.

    That advantage allows Apple to charge a premium for its products. For instance, the average iPhone sold for $873 in the fourth quarter of 2020. By comparison, the average Android smartphone sold for $250 last year. That pricing power has been a tailwind for Apple’s business.

    Not surprisingly, the company has delivered solid financial results over the long term.

    AAPL Revenue (TTM) Chart

    Data by YCharts.

    Since 2016, Apple’s share price has surged over 375%, but shareholders have also benefited from regular dividend payments. Currently, the quarterly payout sits at $0.22 per share, but that figure has gone up every year since 2012. And with Apple’s strong balance sheet, investors should expect that trend to continue.

    Moreover, I think Apple stock is poised to beat the market in the coming years. Its high-margin services business is gaining momentum, and the company reportedly has at least two augmented reality (AR) products in the pipeline, including a pair of AR glasses. Given Apple’s past success with such hardware, I wouldn’t be surprised if both of these products were big winners.

    The company is also developing an autonomous electric vehicle (EV): the so-called Apple Car. In fact, a recent article from Reuters suggests that this AI-powered EV may launch as soon as 2024.

    As a final thought, Apple is Warren Buffett’s largest holding, representing 40% of Berkshire’s portfolio. If the Oracle feels comfortable owning that much Apple stock, I think any investor should consider adding a few shares to their portfolio.

    Mastercard

    Mastercard’s platform connects consumers, merchants, and financial institutions, facilitating electronic payments in over 210 countries and territories. In 2020, the company handled 24% of all card-powered purchase transactions, making Mastercard the third largest payments network in the world.

    For decades, credit and debit cards have been at the core of Mastercard’s business. And despite widespread adoption, this market is still far from saturated. In fact, management believes cash and check transactions account for $68 trillion in global spend each year. For context, card-based transactions account for just $30 trillion.

    However, Mastercard has an even bigger opportunity. Management believes account-based transactions total $139 trillion each year. And rather than rest on its laurels, Mastercard has introduced several new products in an effort to take market share in that category.

    For instance, Mastercard Track targets commercial use cases, simplifying and automating account-based payments between buyers and suppliers. Similarly, Mastercard Send supports account-based P2P payments and disbursements (e.g. government-to-consumer payments).

    Last year, the pandemic created significant headwinds for Mastercard. Even so, the company has managed to grow at a modest pace in recent years.

    Metric 2015 Q1 2021 (TTM) CAGR
    Revenue $9.7 billion $15.5 billion 9%
    Free cash flow $3.8 billion $6.2 billion 10%

    Data source: Mastercard SEC Filings. TTM: trailing 12 months. CAGR: compound annual growth rate.

    Since 2015, Mastercard stock has more than tripled, surging 285%. At the same time, its dividend payments have increased like clockwork every four quarters, even during the pandemic. That underscores the company’s financial stability, and it gives me confidence that Mastercard can weather just about anything.

    Currently, the quarterly dividend sits at $0.44 per share, representing a payout ratio of just 31%. In other words, investors have good reason to believe those annual dividend increases will continue.

    Moreover, given its massive market opportunity and strong competitive position, Mastercard could be a market-beating investment long term. That’s why you should consider adding this stock to your portfolio.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    The post Warren Buffett owns these dividend-paying growth stocks — should you? appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

    *Returns as of May 24th 2021

    More reading

    Trevor Jennewine owns shares of Mastercard. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Apple, Berkshire Hathaway (B shares), and Mastercard. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended the following options: long January 2023 $200 calls on Berkshire Hathaway (B shares), long March 2023 $120 calls on Apple, short January 2023 $200 puts on Berkshire Hathaway (B shares), short January 2023 $265 calls on Berkshire Hathaway (B shares), and short March 2023 $130 calls on Apple. The Motley Fool Australia has recommended Apple, Berkshire Hathaway (B shares), and Mastercard. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    from The Motley Fool Australia https://ift.tt/3jPp4dA